Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
8/29/2023
NMPA Set to Raise the Bar for Conditional Approval Process of New Drug...
8/29/2023
CanSino to Acquire 10% Stake in Malaysian Vaccine Maker Solution
8/29/2023
Mounjaro's China Approval Imminent as Domestic Competitors Enter Clini...
8/28/2023
Regulation of Drug and Medical Device Advertising in China: An Industr...
8/28/2023
Verastem Oncology Enters Partnerships with GenFleet Therapeutics to Ad...
8/28/2023
CDE Solicits Second Round Comments on Two Pharmaceutical Change Resear...
8/28/2023
Chinese Pharma CEOs Emphasize Strategic R&D Selection in Tough Fundrai...
8/25/2023
CDE Seeks Comments on Draft ICH Guidelines M7(R2)
8/25/2023
NMPA Issues Announcement for Applicability of ICH Guidelines Q12
8/25/2023
NMPA Solicits Comments on the Working Procedures for Evaluation and Ap...
8/25/2023
Domestic Pharma Sealed Ten Outlicensing Deals in H1/2023 (Updated)
8/25/2023
IQVIA: Overall Chinese Pharma Market Growth Up 0.3% in 2022
8/25/2023
State Council Adopts New Action Plan for High-quality Development of P...
8/25/2023
Drug R&D and Product Registration News Digest August 2023 (4)
8/25/2023
China: The Latest Medtech Access Policies and Implications
8/25/2023
Patent Linkage in China: What the First Decisions Reveal About the Dir...
8/24/2023
Review of China Performance of Leading MNCs in China H1/2023 (Updated)
8/24/2023
Chinese Consortium Eyes Acquisition of Dominant Polish Pharma Distribu...
8/24/2023
CMS Licenses China Rights of Class 1 Anti-Ischemic Stroke New Drug fro...
8/23/2023
NMPA Appoints New Director General of the CDE
8/23/2023
NMPA Issues the List of Reference Formulations for GQCE Studies (72nd ...
8/23/2023
Chinese and Indonesian Cos Form New Partnerships in Biotech & Healthca...
8/23/2023
What China's New Patent Linkage and Patent Term Extension Systems Mean...
8/23/2023
Increasingly, State Investment and Middle Eastern Sovereign Wealth Are...
8/22/2023
Patent Linkage Litigation in China: A Two-Year Review (The NLR)
8/22/2023
Brand-Name Drugs Feel the Squeeze in China's Generic-Heavy Market (Pod...
8/22/2023
CSPC, Insilico and XtalPi Sign Strategic Collaboration on AI Innovativ...
8/22/2023
Simcere, MabTech Inks Collaborative Agreement for CMAB009 in Mainland ...
8/22/2023
CDE Solicits Comments on Bioequivalence Study Guidelines of Six Generi...
8/22/2023
China Expands Reimbursement of Rare Disease Drugs to Improve Access: N...
Page:
35
/
718
Total number of articles:
21536
:
[First]
[<<]
[33]
[34]
[35]
[36]
[37]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit